Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)

A Cross-sectional, Retrospective Screening and Case-control Study Examining the Frequency of, and Risk Factors Associated With, Impulse Control Disorders in Parkinson's Disease Patients Treated With MIRAPEX® (Pramipexole) and Other Anti-parkinson Agents (DOMINION Study)

Patrocinadores

Patrocinador principal: Boehringer Ingelheim

Fuente Boehringer Ingelheim
Resumen breve

The purpose is to explore the frequency of impulse control disorders in Parkinson's patients treated with different Parkinson's medications.

Estado general Completed
Fecha de inicio September 2006
Fecha de finalización primaria January 2008
Tipo de estudio Observational
Resultado primario
Medida Periodo de tiempo
Occurrence of current ImpulseControl Disorder(ICD) assessed via + res. of Modif.Massachusetts Gambling Screen,Modif.Minnesota Impulsive Disorder Interview for Sexuality,Modif.MIDI for Compulsive Buying,DSM-IV binge-eating research criteria questionnaire 6 months
Resultado secundario
Medida Periodo de tiempo
The occurrence of a past (since onset of PD) ICD 6 months
Demographic and medical history measures up to 14 days after Visit 1
Scores on psychiatric/neuropsychological instruments/tests up to 14 days after Visit 1
Inscripción 3234
Condición
Elegibilidad

Método de muestreo: Non-Probability Sample

Criterios:

Inclusion Criteria:

Observation Criteria:

Male or female outpatients, aged 30 to 75 years of age, with idiopathic PD. Patients must be selected on the basis of a prospective recruitment plan documented at the site, with the objective of obtaining an unbiased representative sample.

Patients must have been treated with anti-parkinson medication for a period of one year or greater and demonstrated a treatment response, in the opinion of the Investigator.

Patients must be willing and able to comply with study procedures. Patients must be willing and able to give meaningful, written informed consent. This must be completed prior to beginning any study procedures, in accordance with GCP and local legislation.

Exclusion Criteria:

Género: All

Edad mínima: 30 Years

Edad máxima: 75 Years

Voluntarios Saludables: No

Oficial general
Apellido Papel Afiliación
Boehringer Ingelheim Study Chair Boehringer Ingelheim
Ubicación
Instalaciones:
248.619.01034 Neurological Physicians of Arizona | Gilbert, Arizona, United States
248.619.01007 Mayo Clinic - Scottsdale | Scottsdale, Arizona, United States
248.619.01025 Sun Health Research Institute | Sun City, Arizona, United States
248.619.01018 Margolin Brain Institute | Fresno, California, United States
248.619.01031 Pacific Neuroscience Medical Group, Inc. | Oxnard, California, United States
248.619.01016 San Francisco VA PD Research, Education, & Clinical Center | San Francisco, California, United States
248.619.01023 The Parkinson's Institute | Sunnyvale, California, United States
248.619.01021 Boehringer Ingelheim Investigational Site | Englewood, Colorado, United States
248.619.01027 Associated Neurologists, P.C. | Danbury, Connecticut, United States
248.619.01013 Molecular NeuroImaging | New Haven, Connecticut, United States
248.619.01020 Parkinson's Disease and Movement Disorders of Boca Raton | Boca Raton, Florida, United States
248.619.01009 University of Florida | Gainesville, Florida, United States
248.619.01035 Emory University | Atlanta, Georgia, United States
248.619.01006 Medical College of Georgia | Augusta, Georgia, United States
248.619.01014 Northwestern University | Chicago, Illinois, United States
248.619.01001 The University of Kansas Medical Center | Kansas City, Kansas, United States
248.619.01015 John Hopkins Hospital | Baltimore, Maryland, United States
248.619.01029 Clinical Neuroscience Center | Southfield, Michigan, United States
248.619.01022 University of Minnesota | Minneapolis, Minnesota, United States
248.619.01008 Robert Wood Johnson Medical School | Piscataway, New Jersey, United States
248.619.01030 Parkinson's Disease and Movement Disorders Center | Albany, New York, United States
248.619.01036 Parkinson's Disease and Mov. Disorders Center of Long Island | Commack, New York, United States
248.619.01017 Weill Cornell medical College | New York, New York, United States
248.619.01003 Duke University Medical Center | Durham, North Carolina, United States
248.619.01028 The Cleveland Clinic Foundation | Cleveland, Ohio, United States
248.619.01004 Lehigh Valley Hospital | Allentown, Pennsylvania, United States
248.619.01010 Parkinson's Disease research, Education and Clinical Center | Philadelphia, Pennsylvania, United States
248.619.01011 University of Pennsylvania | Philadelphia, Pennsylvania, United States
248.619.01024 Thomas Jefferson Hospital | Philadelphia, Pennsylvania, United States
248.619.01019 Boehringer Ingelheim Investigational Site | Pittsburgh, Pennsylvania, United States
248.619.01012 Parkinson's Disease and Movement Disorders Center | Upland, Pennsylvania, United States
248.619.01005 NeuroHealth | Warwick, Rhode Island, United States
248.619.01033 Vanderbilt University Medical Center | Nashville, Tennessee, United States
248.619.01032 Neurology Spclst of Dallas, PA | Dallas, Texas, United States
248.619.01002 Baylor College of Medicine | Houston, Texas, United States
248.619.01026 Neurology/Southeast Parkinson's Disease | Richmond, Virginia, United States
248.619.02011 University of Calgary | Calgary, Alberta, Canada
248.619.02010 The Glenrose Rehab. Hospital | Edmonton, Alberta, Canada
248.619.02009 Movement Disorder Clinic | Winnipeg, Manitoba, Canada
248.619.02005 Health Sciences Centre | St. John's, Newfoundland and Labrador, Canada
248.619.02019 Dr. David King | Halifax, Nova Scotia, Canada
248.619.02013 | Kitchener, Ontario, Canada
248.619.02018 London HSC - University Hospital | London, Ontario, Canada
248.619.02001 Centre for Movement Discorder | Markham, Ontario, Canada
248.619.02008 Ottawa Civic Hospital | Ottawa, Ontario, Canada
248.619.02016 The Toronto Western Hospital | Toronto, Ontario, Canada
248.619.02003 Unite des Troubles du Mouvement | Montreal, Quebec, Canada
248.619.02017 Royal University Hospital | Saskatoon, Saskatchewan, Canada
248.619.02002 Memory and Motor Skills Disorders Clinic | Quebec, Canada
Ubicacion Paises

Canada

United States

Fecha de verificación

November 2013

Fiesta responsable

Nombre Titulo: Boehringer Ingelheim, Study Chair

Organización: Boehringer Ingelheim

Tiene acceso ampliado No
Condición Examinar
Grupo de brazo

Etiqueta: Parkinson's patients

Descripción: Observational study to compare rates of impulse control disorders in patients taking different medications for Parkinson's Disease

Información de diseño del estudio

Modelo de observación: Ecologic or Community

Perspectiva de tiempo: Cross-Sectional

Fuente: ClinicalTrials.gov